Stay updated on UNCOVER-1 Psoriasis Treatment Clinical Trial

Sign up to get notified when there's something new on the UNCOVER-1 Psoriasis Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UNCOVER-1 Psoriasis Treatment Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or revision in the data related to a Phase 3 study assessing the safety and efficacy of LY2439821 compared to placebo in participants with moderate to severe, chronic plaque psoriasis.
    Difference
    0.0%
    Check dated 2024-06-06T14:49:31.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying health conditions and prior treatments required for inclusion in the study. This change provides more specific information about the requirements for study participants.
    Difference
    7%
    Check dated 2024-05-22T21:21:47.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-04-30T22:57:44.000Z thumbnail image

Stay in the know with updates to UNCOVER-1 Psoriasis Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UNCOVER-1 Psoriasis Treatment Clinical Trial page.